Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients
This study was a non-comparative multicenter clinical trial to evaluate the efficacy and tolerability of itraconazole oral solution 200 mg/day (100 mg twice a day in the fasting state) for the treatment of oropharyngeal candidiasis in AIDS patients. We included 50 patients who were treated and follo...
Main Authors: | Flávio Queiroz-Telles, Nanci Silva, Miriam M. Carvalho, Ana Paula Alcântara, Daniel da Matta, Maria G. Barberino, Sergio Bartczak, Arnaldo Lopes Colombo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
|
Series: | Brazilian Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000200003&lng=en&tlng=en |
Similar Items
-
Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients
by: Queiroz-Telles Flávio, et al.
Published: (2001-01-01) -
In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
by: Mohammad Aamir Mirza, et al.
Published: (2012-12-01) -
Chronic mucocutaneous candidiasis
by: Sarita Sasidharanpillai, et al.
Published: (2018-01-01) -
Effectiveness, safety, and tolerability of itraconazole oral solution in pediatric dermatophytosis
by: M Ramesh Bhat, et al.
Published: (2020-01-01) -
An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India
by: Shenoy M, et al.
Published: (2021-09-01)